Vascular graft companies specialize in the design, manufacturing, and distribution of synthetic or biological vascular grafts, crucial in treating vascular diseases and improving blood flow. These grafts serve as conduits for redirecting or replacing damaged blood vessels. Leaders in this industry, such as W.L. Gore & Associates and LeMaitre Vascular, leverage cutting-edge materials and innovative technologies to produce durable and biocompatible grafts.
Latest Vascular Graft Companies Updates:
Terumo: Received FDA approval for the Aortic Zenith™ TX2 device, an expanded indication of their existing Zenith™ platform, offering a minimally invasive option for repairing complex aortic arch aneurysms.
W. L. Gore & Associates: Introduced the Excluder™ AAA System with Tri-Seal Anchoring System, featuring enhanced anchoring technology for improved long-term outcomes in abdominal aortic aneurysm (AAA) repair.
Getinge: Developed the Maquet Biograft™ Hybrid AAA Stent-Graft, combining a synthetic stent-graft with a collagen-based endothelial lining, aiming to reduce the risk of complications associated with traditional grafts.
BD: Acquired C. R. Bard, Inc., gaining access to Bard's vascular access and peripheral intervention portfolio, further solidifying its position in the cardiovascular device market.Abbott: Partnered with Cardival Biosciences to develop and commercialize novel bioresorbable vascular scaffolds, offering a next-generation alternative to traditional stents that eventually need removal.
List of Vascular Graft Key companies in the market:
Vascular Graft Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)